Identification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coli

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 20, 2010, Pages 9072-9077

  Moriel, Danilo Gomes ^a   Bertoldi, Isabella ^a   Spagnuolo, Angela ^a   Marchi, Sara ^a   Rosini, Roberto ^a   Nesta, Barbara ^a   Pastorello, Ilaria ^a   Mariani Corea, Vanja A ^a   Torricelli, Giulia ^a   Cartocci, Elena ^a   Savino, Silvana ^a   Scarselli, Maria ^a   Dobrindt, Ulrich ^b   Hacker, Jörg ^b,c   Tettelin, Hervé ^d,g   Tallon, Luke J ^d,g   Sullivan, Steven ^d,h   Wieler, Lothar H ^e   Ewers, Christa ^e   Pickard, Derek ^f   Dougan, Gordon ^f   Fontana, Maria Rita ^a   Rappuoli, Rino ^a   Pizza, Mariagrazia ^a   Serino, Laura ^a   more..

^a NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c German Academy of Sciences Leopoldina   (Germany)

^d J CRAIG VENTER INSTITUTE   (United States)

^e FREIE UNIVERSITÄT BERLIN   (Germany)

^f WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^g UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^h NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Sepsis; Urinary tract infections

Indexed keywords

ANTIGEN; HEMOLYSIN; LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG EFFICACY; ESCHERICHIA COLI; FEMALE; GENE IDENTIFICATION; GENE SEQUENCE; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEPSIS;

ANIMALS; ANTIGENS, BACTERIAL; BASE SEQUENCE; COMPUTATIONAL BIOLOGY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI VACCINES; FINLAND; GENOME, BACTERIAL; GENOMIC ISLANDS; HUMANS; MENINGITIS, ESCHERICHIA COLI; MICE; MOLECULAR SEQUENCE DATA; SECRETORY PATHWAY; SEQUENCE ANALYSIS, DNA;

AVES; ESCHERICHIA COLI; MAMMALIA;

EID: 77952692819     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0915077107     Document Type: Article

References (54)

1. Kaper JB, Nataro JP, Mobley HL (2004) Pathogenic Escherichia coli. Nat Rev Microbiol 2 (2):123-140.
2. Blattner FR, et al. (1997) The complete genome sequence of Escherichia coli K-12. Science 277(5331):1453-1474.
3. Ogura Y, et al. (2009) Comparative genomics reveal the mechanism of the parallel evolution of O157 and non-O157 enterohemorrhagic Escherichia coli. Proc Natl Acad Sci USA 106(42):17939-17944.
4. Ahmed N, Dobrindt U, Hacker J, Hasnain SE (2008) Genomic fluidity and pathogenic bacteria: applications in diagnostics, epidemiology and intervention. Nat Rev Microbiol 6(5):387-394. (Pubitemid 351552659)
5. Russo TA, Johnson JR (2003) Medical and economic impact of extraintestinal infections due to Escherichia coli: Focus on an increasingly important endemic problem. Microbes Infect 5(5):449-456.
6. Russo TA, Johnson JR (2006) Extraintestinal isolates of Escherichia coli: Identification and prospects for vaccine development. Expert Rev Vaccines 5(1):45-54.
7. Moriel DG, et al. (2008) Genome-based vaccine development - A shortcut for the future. Hum Vaccines 4(3):184-188.
8. Achtman M, et al. (1983) Six widespread bacterial clones among Escherichia coli K1 isolates. Infect Immun 39(1):315-335. (Pubitemid 13212533)
9. Bingle LE, Bailey CM, PallenMJ (2008) Type VI secretion: A beginner's guide. Curr Opin Microbiol 11(1):3-8.
10. Dobrindt U, et al. (2001) S-Fimbria-encoding determinant sfa(I) is located on pathogenicity island III(536) of uropathogenic Escherichia colistrain 536. Infect Immun 69(7):4248-4256. (Pubitemid 32574420)
11. Ulett GC, et al. (2007) Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in long-term persistence in the urinary tract. Infect Immun 75 (7):3233-3244.
12. Russo TA, et al. (2002) IroN functions as a siderophore receptor and is a urovirulence factor in an extraintestinal pathogenic isolate of Escherichia coli. Infect Immun 70 (12):7156-7160.
13. SabriM, et al. (2008) Contribution of the SitABCD, MntH, and FeoB metal transporters to the virulence of an avian pathogenic Escherichia coli (APEC) O78 strain. Infect Immun 76(2):601-611.
14. Schubert S, Picard B, Gouriou S, Heesemann J, Denamur E (2002) Yersinia high-pathogenicity island contributes to virulence in Escherichia coli causing extraintestinal infections. Infect Immun 70(9):5335-5337.
15. Heywood W, Henderson B, Nair SP (2005) Cytolethal distending toxin: Creating a gap in the cell cycle. J Med Microbiol 54(Pt 3):207-216. (Pubitemid 40879610)
16. Nougayrede JP, et al. (2006) Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 313(5788):848-851. (Pubitemid 44223356)
17. Sandt CH, Hopper JE, Hill CW (2002) Activation of prophage eibgenes for immunoglobulin- binding proteins by genes from the IbrAB genetic island of Escherichia coli ECOR-9. J Bacteriol 184(13):3640-3648.
18. Wieler LH, et al. (1996) The enterohemolysin phenotype of bovine Shiga-like toxin-producing Escherichia coli (SLTEC) is encoded by the EHEC-hemolysin gene. Vet Microbiol 52(1-2):153-164.
19. Cianciotto NP (2005) Type II secretion: A protein secretion system for all seasons. Trends Microbiol 13(12):581-588. (Pubitemid 41661339)
20. Pluschke G, Achtman M (1985) Antibodies to O-antigen of lipopolysaccharide are protective against neonatal infection with Escherichia coli K1. Infect Immun 49 (2):365-370. (Pubitemid 15004866)
21. Zou Y, He L, Chi F, Jong A, Huang SH (2008) Involvement of Escherichia coliK1 ibeTin bacterial adhesion that is associated with the entry into human brain microvascular endothelial cells. Med Microbiol Immunol 197(4):337-344.
22. Huang SH, Wan ZS, Chen YH, Jong AY, Kim KS (2001) Further characterization of Escherichia coli brain microvascular endothelial cell invasion gene ibeA by deletion, complementation, and protein expression. J Infect Dis 183(7):1071-1078.
23. Johnson TJ, et al. (2007) The genome sequence of avian pathogenic Escherichia coli strain O1:K1:H7 shares strong similarities with human extraintestinal pathogenic E. coli genomes. J Bacteriol 189(8):3228-3236.
24. Touchon M, et al. (2009) Organised genome dynamics in the Escherichia coli species results in highly diverse adaptive paths. PLoS Genet 5(1):e1000344.
25. Chen SL, et al. (2006) Identification of genes subject to positive selection in uropathogenic strains of Escherichia coli: A comparative genomics approach. Proc Natl Acad Sci USA 103(15):5977-5982.
26. Welch RA, et al. (2002) Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc Natl Acad Sci USA 99 (26):17020-17024.
27. Brzuszkiewicz E, et al. (2006) How to become a uropathogen: Comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains. Proc Natl Acad Sci USA 103(34):12879-12884. (Pubitemid 44298655)
28. Mokady D, Gophna U, Ron EZ (2005) Extensive gene diversity in septicemic Escherichia coli strains. J Clin Microbiol 43(1):66-73. (Pubitemid 40096281)
29. Bielaszewska M, et al. (2007) Aspects of genome plasticity in pathogenic Escherichia coli. Int J Med Microbiol 297(7-8):625-639. (Pubitemid 47575958)
30. Sandkvist M (2001) Biology of type II secretion. Mol Microbiol 40(2):271-283.
31. Peterson KM, Mekalanos JJ (1988) Characterization of the Vibrio cholerae ToxR regulon: identification of novel genes involved in intestinal colonization. Infect Immun 56(11):2822-2829.
32. Gentschev I, Dietrich G, Goebel W (2002) The E. colialpha-hemolysin secretion system and its use in vaccine development. Trends Microbiol 10(1):39-45. (Pubitemid 34075263)
33. O'Hanley P, Lalonde G, Ji G (1991) Alpha-hemolysin contributes to the pathogenicity of piliated digalactoside-binding Escherichia coli in the kidney: Efficacy of an alpha-hemolysin vaccine in preventing renal injury in the BALB/c mouse model of pyelonephritis. Infect Immun 59(3):1153-1161.
34. Ouyang Z, Isaacson R (2006) Identification and characterization of a novel ABC iron transport system, fit, in Escherichia coli. Infect Immun 74(12):6949-6956. (Pubitemid 44913170)
35. Chen Q, Savarino SJ, Venkatesan MM (2006) Subtractive hybridization and optical mapping of the enterotoxigenic Escherichia coli H10407 chromosome: Isolation of unique sequences and demonstration of significant similarity to the chromosome of E. coli K-12. Microbiology 152(Pt 4):1041-1054.
36. Antao EM, et al. (2009) Signature-tagged mutagenesis in a chicken infection model leads to the identification of a novel avian pathogenic Escherichia coli fimbrial adhesin. PLoS One 4(11):e7796.
37. Roberts JA, et al. (2004) Antibody responses and protection from pyelonephritis following vaccination with purified Escherichia coli PapDG protein. J Urol 171 (4):1682-1685.
38. Langermann S, et al. (1997) Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science 276(5312):607-611. (Pubitemid 27193687)
39. Russo TA, Carlino-Macdonald U (2008) Extraintestinal pathogenic isolates of Escherichia colido not possess active IgA(1), IgA(2), sIgA or IgG proteases. FEMS Immunol Med Microbiol 53(1):65-71.
40. Russo TA, et al. (2007) A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. colistrain is a vaccine candidate. Vaccine 25(19):3859-3870.
41. Russo TA, et al. (2003) The Siderophore receptor IroN of extraintestinal pathogenic Escherichia coli is a potential vaccine candidate. Infect Immun 71(12):7164-7169.
42. Alteri CJ, Hagan EC, Sivick KE, Smith SN, Mobley HL (2009) Mucosal immunization with iron receptor antigens protects against urinary tract infection. PLoS Pathog 5(9): e1000586.
43. Durant L, et al. (2007) Identification of candidates for a subunit vaccine against extraintestinal pathogenic Escherichia coli. Infect Immun 75(4):1916-1925. (Pubitemid 46559461)
44. Pizza M, et al. (2000) Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287(5459):1816-1820.
45. Tettelin H, et al. (2002) Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae. Proc Natl Acad Sci USA 99(19):12391-12396.
46. Nakai K, Kanehisa M (1991) Expert system for predicting protein localization sites in gram-negative bacteria. Proteins 11(2):95-110.
47. Gardy JL, et al. (2005) PSORTb v.2.0: Expanded prediction of bacterial protein subcellular localization and insights gained from comparative proteome analysis. Bioinformatics 21(5):617-623.
48. Scorza FB, et al. (2008) Proteomics characterization of outer membrane vesicles from the extraintestinal pathogenic Escherichia coli ΔtolR IHE3034 mutant. Mol Cell Proteomics 7(3):473-485.
49. Wirth T, et al. (2006) Sex and virulence in Escherichia coli: An evolutionary perspective. Mol Microbiol 60(5):1136-1151. (Pubitemid 43920175)
50. Sankar TS, et al. (2009) Fate of the H-NS-repressed bgl operon in evolution of Escherichia coli. PLoS Genet 5(3):e1000405.
51. Ewers C, Antao EM, Diehl I, Philipp HC, Wieler LH (2009) Intestine and environment of the chicken as reservoirs for extraintestinal pathogenic Escherichia coli strains with zoonotic potential. Appl Environ Microbiol 75(1):184-192.
52. Ghai R, Hain T, Chakraborty T (2004) GenomeViz: Visualizing microbial genomes. BMC Bioinformatics 5:198.
53. Dobrindt U, et al. (2002) Genetic structure and distribution of four pathogenicity islands (PAI I(536) to PAI IV(536)) of uropathogenic Escherichia coli strain 536. Infect Immun 70(11):6365-6372. (Pubitemid 35192729)
54. Lloyd AL, Rasko DA, Mobley HL (2007) Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli. J Bacteriol 189(9):3532-3546. (Pubitemid 46668818)